Legend Biotech (LEGN) Change in Working Capital (2022 - 2023)
Legend Biotech (LEGN) posted Change in Working Capital of -$74.9 million for Q3 2023, up 42.09% on a QoQ basis from -$129.4 million in Q3 2022, and up 42.09% year-over-year from -$52.7 million in Q3 2022.
Legend Biotech (LEGN) Change in Working Capital (2022 - 2023) Analysis & Trends
Legend Biotech's Change in Working Capital history runs 2 years deep, the most recent figure standing at -$74.9 million for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -74.93 Mn |
| Sep 30, 2023 | -74.93 Mn |
| Sep 30, 2022 | -129.39 Mn |
| Sep 30, 2022 | -129.39 Mn |